Mortality Risks and Life Expectancy Losses from COVID-19 Infections by Age for the United States

Abstract

We look at COVID-19 mortality and expected life expectancy risks by age prior to the development of pharmaceutical treatments for the SARS-CoV-2 virus. A COVID-19 infection more than doubled the annual mortality risks for Americans over sixty. Americans aged sixty or older stand to lose 153 to 222 days of life expectancy from contracting COVID-19 without the benefits of pharmaceutical treatments or vaccines.

Note: Funding: I received no funding for the study.

Declaration of Interests: I have no conflicts of interest with regard to "Mortality Risks and Life Expectancy Losses from COVID-19 Infections by Age for the United States."

Keywords: actuarial tables, mortality, death rates, CFR, COVID-19, IFR, SARS-CoV-2

JEL Classification: G22, I1, I18, J31, J65, K32